Amr Soliman to Breast Neoplasms
This is a "connection" page, showing publications Amr Soliman has written about Breast Neoplasms.
Connection Strength
5.785
-
Carew JW, Radulescu SC, Zhang L, Ungurean C, Calomfirescu C, Furtunescu F, Soliman AS. Breast cancer mortality in Romania: trends, regional and rural-urban inequalities, and policy implications. BMC Cancer. 2025 Jul 01; 25(1):1038.
Score: 0.420
-
Barkana BD, El-Sayed A, Khaled RH, Helal M, Khaled H, Deeb R, Pitcher M, Pfeiffer R, Roubidoux M, Schairer C, Soliman AS. Imaging Modalities in Inflammatory Breast Cancer (IBC) Diagnosis: A Computer-Aided Diagnosis System Using Bilateral Mammography Images. Sensors (Basel). 2022 Dec 21; 23(1).
Score: 0.352
-
Cherlin DS, Mwaiselage J, Msami K, Heisler Z, Young H, Cui Q, Soliman AS. Breast Cancer Screening in Low-Income Countries: A New Program for Downstaging Breast Cancer in Tanzania. Biomed Res Int. 2022; 2022:9795534.
Score: 0.335
-
Al Balushi S, Al Rawahi Y, Al Kharusi W, Al Bahrani B, Al Baimani K, Meza J, Roubidoux MA, Chamberlain RM, Soliman AS. Needs for Cancer Education In Oman Based on the Breast Cancer Screening Program. J Cancer Educ. 2021 07; 36(Suppl 1):78-86.
Score: 0.317
-
Heisler Z, Eastwood B, Mwaiselage J, Kahesa C, Msami K, Soliman AS. Return on Investment of a Breast Cancer Screening Program in Tanzania: Opportunity for Patient and Public Education. J Cancer Educ. 2022 06; 37(3):701-708.
Score: 0.302
-
Schairer C, Hablas A, Eldein IAS, Gaafar R, Rais H, Mezlini A, Ayed FB, Ayoub WB, Benider A, Tahri A, Khouchani M, Aboulazm D, Karkouri M, Eissa S, Bastawisy AE, Yehia M, Gadalla SM, Swain SM, Merajver SD, Brown LM, Pfeiffer RM, Soliman AS. Risk factors for inflammatory and non-inflammatory breast cancer in North Africa. Breast Cancer Res Treat. 2020 Nov; 184(2):543-558.
Score: 0.300
-
Yang K, Msami K, Calixte R, Mwaiselage J, Dorn J, Soliman AS. Educational Opportunities for Down-Staging Breast Cancer in Low-Income Countries: an Example from Tanzania. J Cancer Educ. 2019 Dec; 34(6):1225-1230.
Score: 0.285
-
Schairer C, Hablas A, Eldein IAS, Gaafar R, Rais H, Mezlini A, Ayed FB, Ayoub WB, Benider A, Tahri A, Khouchani M, Aboulazm D, Karkouri M, Eissa S, Pfeiffer RM, Gadalla SM, Swain SM, Merajver SD, Brown LM, Soliman AS. Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa. Breast Cancer Res Treat. 2019 Jul; 176(2):407-417.
Score: 0.273
-
Obrist M, Osei-Bonsu E, Awuah B, Watanabe-Galloway S, Merajver SD, Schmid K, Soliman AS. Factors related to incomplete treatment of breast cancer in Kumasi, Ghana. Breast. 2014 Dec; 23(6):821-8.
Score: 0.199
-
Roen EL, Copeland GE, Pinagtore NL, Meza R, Soliman AS. Disparities of cancer incidence in Michigan's American Indians: spotlight on breast cancer. Cancer. 2014 Jun 15; 120(12):1847-53.
Score: 0.192
-
Roen EL, Roubidoux MA, Joe AI, Russell TR, Soliman AS. Adherence to screening mammography among American Indian women of the Northern Plains. Breast Cancer Res Treat. 2013 Jun; 139(3):897-905.
Score: 0.182
-
Uddin N, Fateem E, Hablas A, Seifeldin IA, Brown E, Merajver SD, Soliman AS. Public and professional educational needs for downstaging breast cancer in Egypt. J Cancer Educ. 2012 Mar; 27(1):149-55.
Score: 0.167
-
Mousa SM, Seifeldin IA, Hablas A, Elbana ES, Soliman AS. Patterns of seeking medical care among Egyptian breast cancer patients: relationship to late-stage presentation. Breast. 2011 Dec; 20(6):555-61.
Score: 0.160
-
Stapleton JM, Mullan PB, Dey S, Hablas A, Gaafar R, Seifeldin IA, Banerjee M, Soliman AS. Patient-mediated factors predicting early- and late-stage presentation of breast cancer in Egypt. Psychooncology. 2011 May; 20(5):532-7.
Score: 0.157
-
Arshad S, Williams KP, Mabiso A, Dey S, Soliman AS. Evaluating the knowledge of breast cancer screening and prevention among Arab-American women in Michigan. J Cancer Educ. 2011 Mar; 26(1):135-8.
Score: 0.155
-
Boxwala FI, Bridgemohan A, Griffith DM, Soliman AS. Factors associated with breast cancer screening in Asian Indian women in metro-Detroit. J Immigr Minor Health. 2010 Aug; 12(4):534-43.
Score: 0.149
-
Soliman AS, Banerjee M, Lo AC, Ismail K, Hablas A, Seifeldin IA, Ramadan M, Omar HG, Fokuda A, Harford JB, Merajver SD. High proportion of inflammatory breast cancer in the Population-based Cancer Registry of Gharbiah, Egypt. Breast J. 2009 Jul-Aug; 15(4):432-4.
Score: 0.138
-
Lo AC, Georgopoulos A, Kleer CG, Banerjee M, Omar S, Khaled H, Eissa S, Hablas A, Omar HG, Douglas JA, Merajver SD, Soliman AS. Analysis of RhoC expression and lymphovascular emboli in inflammatory vs non-inflammatory breast cancers in Egyptian patients. Breast. 2009 Feb; 18(1):55-9.
Score: 0.134
-
Lo AC, Kleer CG, Banerjee M, Omar S, Khaled H, Eissa S, Hablas A, Douglas JA, Alford SH, Merajver SD, Soliman AS. Molecular epidemiologic features of inflammatory breast cancer: a comparison between Egyptian and US patients. Breast Cancer Res Treat. 2008 Nov; 112(1):141-7.
Score: 0.124
-
Sherr HR, Soliman AS, Bertrand KA, Hirko KA. Persistent poverty and late-stage breast cancer diagnosis in the USA: impacts of rural residence, race, and time within Surveillance, Epidemiology, and End Results registries, 2004 to 2021. Cancer Causes Control. 2025 Nov; 36(11):1589-1597.
Score: 0.106
-
Carvalho MM, Bah A, Azrib S, Hiatt RA, Boutayeb S, Belyamani L, Soliman AS, Khalis M. Evaluation of performance indicators of a national breast cancer screening program in Casablanca, Morocco. BMC Cancer. 2025 Apr 04; 25(1):612.
Score: 0.103
-
Soliman AS, Vulimiri SV, Kleiner HE, Shen J, Eissa S, Morad M, Taha H, Lukmanji F, Li D, Johnston DA, Lo HH, Lau S, Digiovanni J, Bondy ML. High levels of oxidative DNA damage in lymphocyte DNA of premenopausal breast cancer patients from Egypt. Int J Environ Health Res. 2004 Apr; 14(2):121-34.
Score: 0.096
-
Soliman AS, Wang X, DiGiovanni J, Eissa S, Morad M, Vulimiri S, Mahgoub KG, Johnston DA, Do KA, Seifeldin IA, Boffetta P, Bondy ML. Serum organochlorine levels and history of lactation in Egypt. Environ Res. 2003 Jun; 92(2):110-7.
Score: 0.091
-
Charaka H, Khalis M, Elfakir S, Huybrechts I, Khazraji YC, Lyoussi B, Soliman AS, Nejjari C. Knowledge, Perceptions, and Satisfaction of Moroccan Women Towards a New Breast Cancer Screening Program in Morocco. J Cancer Educ. 2021 08; 36(4):657-663.
Score: 0.080
-
Valencia D, Granda P, Pesce V, Di Sibio A, Soliman AS, G?mez J, Ramos I, Gallardo P. Argentina's National Program for Control of Breast Cancer: Time 1, Patient Navigation, and Patient Cancer Education Experience. J Cancer Educ. 2022 12; 37(6):1669-1676.
Score: 0.079
-
Khalis M, Dossus L, Rinaldi S, Biessy C, Moskal A, Charaka H, Fort E, His M, Mellas N, Nejjari C, Charbotel B, Soliman AS, Romieu I, Chaj?s V, Gunter MJ, Huybrechts I, El Rhazi K. Body size, silhouette trajectory and the risk of breast cancer in a Moroccan case-control study. Breast Cancer. 2020 Jul; 27(4):748-758.
Score: 0.073
-
Khalis M, El Rhazi K, Fort E, Chaj?s V, Charaka H, Huybrechts I, Moskal A, Biessy C, Romieu I, Abbass F, El Marnissi B, Mellas N, Nejjari C, Soliman AS, Charbotel B. Occupation and risk of female breast cancer: A case-control study in Morocco. Am J Ind Med. 2019 10; 62(10):838-846.
Score: 0.070
-
Khalis M, Chaj?s V, Moskal A, Biessy C, Huybrechts I, Rinaldi S, Dossus L, Charaka H, Mellas N, Nejjari C, Dorn J, Soliman AS, Romieu I, El Rhazi K, Charbotel B. Healthy lifestyle and breast cancer risk: A case-control study in Morocco. Cancer Epidemiol. 2019 02; 58:160-166.
Score: 0.067
-
Skrundevskiy AN, Omar OS, Kim J, Soliman AS, Korolchuk TA, Wilson FA. Return on Investment Analysis of Breast Cancer Screening and Downstaging in Egypt: Implications for Developing Countries. Value Health Reg Issues. 2018 Sep; 16:22-27.
Score: 0.063
-
Kim YC, Soliman AS, Cui J, Ramadan M, Hablas A, Abouelhoda M, Hussien N, Ahmed O, Zekri AN, Seifeldin IA, Wang SM. Unique Features of Germline Variation in Five Egyptian Familial Breast Cancer Families Revealed by Exome Sequencing. PLoS One. 2017; 12(1):e0167581.
Score: 0.058
-
Schlichting JA, Soliman AS, Schairer C, Harford JB, Hablas A, Ramadan M, Seifeldin I, Merajver SD. Breast cancer by age at diagnosis in the Gharbiah, Egypt, population-based registry compared to the United States Surveillance, Epidemiology, and End Results Program, 2004-2008. Biomed Res Int. 2015; 2015:381574.
Score: 0.053
-
Scherber S, Soliman AS, Awuah B, Osei-Bonsu E, Adjei E, Abantanga F, Merajver SD. Characterizing breast cancer treatment pathways in Kumasi, Ghana from onset of symptoms to final outcome: outlook towards cancer control. Breast Dis. 2014 Jan 01; 34(4):139-49.
Score: 0.047
-
Akinyemiju TF, Soliman AS, Copeland G, Banerjee M, Schwartz K, Merajver SD. Trends in breast cancer stage and mortality in Michigan (1992-2009) by race, socioeconomic status, and area healthcare resources. PLoS One. 2013; 8(4):e61879.
Score: 0.045
-
Wojcinski S, Soliman AA, Schmidt J, Makowski L, Degenhardt F, Hillemanns P. Sonographic features of triple-negative and non-triple-negative breast cancer. J Ultrasound Med. 2012 Oct; 31(10):1531-41.
Score: 0.043
-
Schlichting JA, Soliman AS, Schairer C, Schottenfeld D, Merajver SD. Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008. Breast Cancer Res Treat. 2012 Aug; 134(3):1257-68.
Score: 0.043
-
Schlichting JA, Soliman AS, Schairer C, Banerjee M, Rozek LS, Schottenfeld D, Harford JB, Merajver SD. Association of inflammatory and noninflammatory breast cancer with socioeconomic characteristics in the Surveillance, Epidemiology, and End Results database, 2000-2007. Cancer Epidemiol Biomarkers Prev. 2012 Jan; 21(1):155-65.
Score: 0.041
-
Spencer B, Banerjee M, Omar S, Khaled H, Anwar N, Zaghloul MS, Eissa S, Kleer CG, Dey S, Merajver SD, Soliman AS. Survival of inflammatory breast cancer patients compared to non-inflammatory breast cancer patients in Egypt. Breast J. 2011 Sep-Oct; 17(5):545-7.
Score: 0.040
-
Dey S, Soliman AS, Hablas A, Seifeldein IA, Ismail K, Ramadan M, El-Hamzawy H, Wilson ML, Banerjee M, Boffetta P, Harford J, Merajver SD. Urban-rural differences in breast cancer incidence in Egypt (1999-2006). Breast. 2010 Oct; 19(5):417-23.
Score: 0.037
-
Burson AM, Soliman AS, Ngoma TA, Mwaiselage J, Ogweyo P, Eissa MS, Dey S, Merajver SD. Clinical and epidemiologic profile of breast cancer in Tanzania. Breast Dis. 2010; 31(1):33-41.
Score: 0.036
-
Dey S, Boffetta P, Mathews A, Brennan P, Soliman A, Mathew A. Risk factors according to estrogen receptor status of breast cancer patients in Trivandrum, South India. Int J Cancer. 2009 Oct 01; 125(7):1663-70.
Score: 0.035
-
Dey S, Soliman AS, Hablas A, Seifeldin IA, Ismail K, Ramadan M, El-Hamzawy H, Wilson ML, Banerjee M, Boffetta P, Harford J, Merajver SD. Urban-rural differences in breast cancer incidence by hormone receptor status across 6 years in Egypt. Breast Cancer Res Treat. 2010 Feb; 120(1):149-60.
Score: 0.035
-
Dey S, Soliman AS, Merajver SD. Xenoestrogens may be the cause of high and increasing rates of hormone receptor positive breast cancer in the world. Med Hypotheses. 2009 Jun; 72(6):652-6.
Score: 0.034
-
Hensley Alford S, Schwartz K, Soliman A, Johnson CC, Gruber SB, Merajver SD. Breast cancer characteristics at diagnosis and survival among Arab-American women compared to European- and African-American women. Breast Cancer Res Treat. 2009 Mar; 114(2):339-46.
Score: 0.032
-
Shah NM, Soliman AS, Benerjee M, Merajver SD, Ismail K, Seifeldin I, Hablas A, Zarzour A, Abdel-Aziz A, Ben Ayed F, Chamberlain RM. Knowledge gained after a brief CME module on breast cancer diagnosis. J Cancer Educ. 2006; 21(3):169-74.
Score: 0.027
-
Akinyemiju TF, Soliman AS, Yassine M, Banerjee M, Schwartz K, Merajver S. Healthcare access and mammography screening in Michigan: a multilevel cross-sectional study. Int J Equity Health. 2012 Mar 21; 11:16.
Score: 0.010